Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis.
Chen W, Zhang J, Zhong W, Liu Y, Lu Y, Zeng Z, Huang H, Wan X, Meng X, Zou F, Cai S, Dong H.
Chen W, et al. Among authors: zeng z.
Front Pharmacol. 2021 Sep 16;12:744826. doi: 10.3389/fphar.2021.744826. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34603058
Free PMC article.